הקרן לבריאות וסביבה | סרטן השד והסביבה | 2015

12 מקורות על הסכמתם לשימוש במידע המדעי שאספו ופרסמו על סרטן השד והסביבה ושהיווה בסיס לפרסום זה: Breast Cancer Fund ברצוננו להודות ל Breast Cancer Fund (2015). Clear Science: http://www.breastcancerfund.org/clear-science/ (r etrieved July 2015).  American Cancer Society (2011). Cancer facts & figures, 2011 . http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf (re trieved July 2015).  DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014). Breast cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 64 (1), 52–62.  Forman, M.R., Winn, D.M., Collman, G.W., Rizzo, J., & Birnbaum, L.S. (2014). Environmental exposures, breast development and cancer risk: Through the looking glass of breast cancer prevention. Reproductive Toxicology, 54 , 6-10. / עמוד 2 סרטן השד והסביבה  Birnbaum, L.S., & Fenton, S.E. (2003). Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 111 (4), 389-394  Fenton, S.E. (2006). Endocrine-disrupting compounds and mammary gland development: Early exposure and later life consequences. Endocrinology, 147 (S6), S18-24.  Russo, J., Hu, Y.F., Silva, I.D., & Russo, I.H. (2001). Cancer risk related to mammary gland structure and development. Microscopy Research and Technique, 52 (2), 204-223. / עמוד 3 התפתחות השד  Rajapakse, N., Ong, D., & Kortenkamp, A. (2001). Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicological Sciences, 60 (2), 296-304.  Rajapakse, N., Silva, E., & Kortenkamp, A. (2002). Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environmental Health Perspectives, 110 (9), 917–921. / עמוד 3 תערובות כימיקלים  Birnbaum, L.S., & Fenton, S.E. (2003). Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives, 111 (4), 389-394  Fenton, S.E. (2006). Endocrine-disrupting compounds and mammary gland development: Early exposure and later life consequences. Endocrinology, 147 (S6), S18-24.  Hankinson, S.E., Colditz, G.A., &Willett, W.C. (2004). Towards an integrated model for breast cancer etiology: The lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Research, 6 (5), 213-218.  Kruk, J., & Aboul-Enein, H.Y. (2006). Environmental exposure and other behavioral risk factors in breast cancer. Current Cancer Therapy Reviews, 2 , 3-21.  Lux, M.P., Fasching, P.A., & Beckmann, M.W. (2006). Hereditary breast and ovarian cancer: Review and future perspectives. Journal of Molecular Medicine, 84 (1), 16-28.  Michels, K.B., Mohllajee, A.P., Roset-Bahmanyar, E., Beehler, G.P., & Moysich, K.B. (2007). Diet and breast cancer: A review of the prospective observational studies. Cancer, 109 (S12), 2712-2749.  Monninkhof, E.M., Elias, S.G., Vlems, F.A., van der Tweel, I., Schuit, A.J., Voskuil, D.W. & van Leeuwen, F.E., TFPAC (2007). Physical activity and breast cancer: A systematic review. Epidemiology, 18 (1), 137-157.  Nickerson, K. (2006). Environmental contaminants in breast milk. Journal of Midwifery and Women’s Health, 51 (1), 26-34.  Office of Pollution Prevention andToxics, Environmental Protection Agency (2007). Overview: Office of pollution prevention and toxics programs . http://www. epa.gov/opptintr/pubs/oppt101c2.pdf (retrieved July 2015).  Rudel, R.A., Attfield, K.A., Schifano, J.N., & Brody, J.G. (2007). Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer, 109 (S12), 2635-2666.  Rudel, R.A., Camann, D.E., Spengler, J.D., Korn, L.R., & Brody, J.G. (2003). Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in air and dust. Environmental Science and Technology, 37 (20), 4543-4553.  Siddiqui, M.K.J., Anand, M., Mehrotra, P.K., Sarangi, R., & Mathur, N. (2004). Biomonitoring of organochlorines in women with benign and malignant breast disease. Environmental Research, 98 (2), 250-257.  Visvanathan, K., Crum, R.M., Strickland, P.T., You, X., Ruczinski, I., Berndt, S.I., Alberg, A.J., Hoffman, S.C., Comstock, G.W., Bell, D.A., & Helzlsouer, K.J. (2007). Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcoholism: Clinical and Experimental Research, 31 (3), 467-476.  Zheng, S.M., Lee, I.M., Manson, J.E., Cook, N.R., Willett, W.C., & Buring, J.E. (2007). Alcohol consumption and breast cancer risk in the Women’s Health Study. American Journal of Epidemiology, 165 (6), 667-676. / עמוד 3 כימיקלים בסביבה שלנו

RkJQdWJsaXNoZXIy NjcyMg==